Monopolies, not markets, set U.S. drug prices
Drug prices are outrageously high in America because the U.S. government patent process allows corporations to maintain monopolies on new, essential, and sometimes life-saving medications. Corporations have a single, sworn duty: To maximize shareholder profits. This means raising prices as … Continue reading Monopolies, not markets, set U.S. drug prices
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed